- Home
- WTBA vs CLLS Comparison
WTBA vs CLLS Comparison
Compare WTBA & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTBA
- CLLS
- Stock Information
- Founded
- WTBA 1893
- CLLS 1999
- Country
- WTBA United States
- CLLS France
- Employees
- WTBA N/A
- CLLS N/A
- Industry
- WTBA Major Banks
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- WTBA Finance
- CLLS Health Care
- Exchange
- WTBA Nasdaq
- CLLS Nasdaq
- Market Cap
- WTBA 342.0M
- CLLS 299.0M
- IPO Year
- WTBA N/A
- CLLS 2007
- Fundamental
- Price
- WTBA $21.53
- CLLS $3.85
- Analyst Decision
- WTBA Hold
- CLLS Buy
- Analyst Count
- WTBA 2
- CLLS 1
- Target Price
- WTBA $23.50
- CLLS $8.00
- AVG Volume (30 Days)
- WTBA 35.9K
- CLLS 76.7K
- Earning Date
- WTBA 10-23-2025
- CLLS 11-07-2025
- Dividend Yield
- WTBA 4.56%
- CLLS N/A
- EPS Growth
- WTBA 49.53
- CLLS N/A
- EPS
- WTBA 1.90
- CLLS N/A
- Revenue
- WTBA $91,783,000.00
- CLLS $82,551,000.00
- Revenue This Year
- WTBA $25.05
- CLLS N/A
- Revenue Next Year
- WTBA $10.87
- CLLS $58.00
- P/E Ratio
- WTBA $11.53
- CLLS N/A
- Revenue Growth
- WTBA 19.66
- CLLS 129.04
- 52 Week Low
- WTBA $17.31
- CLLS $1.10
- 52 Week High
- WTBA $24.85
- CLLS $5.48
- Technical
- Relative Strength Index (RSI)
- WTBA 62.51
- CLLS 58.54
- Support Level
- WTBA $21.12
- CLLS $3.49
- Resistance Level
- WTBA $22.13
- CLLS $3.86
- Average True Range (ATR)
- WTBA 0.54
- CLLS 0.22
- MACD
- WTBA 0.02
- CLLS 0.03
- Stochastic Oscillator
- WTBA 81.82
- CLLS 89.76
About WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.